EAGLE PHARMACEUTICALS, INC. - COM (EGRX)

Historical Portfolio Holders from Q1 2014 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM
Shares, excl. options Q3 2024
8.48M
Holdings value Q3 2024
$31.6M
Value change Q3 2024
-$6.59M
Grand Portfolio weight change Q3 2024
0%
Number of holders
63
Number of buys Q3 2024
21
Number of sells Q3 2024
-45
Average buys Q3 2024 %
+0%
Average sells Q3 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 8.48M $31.6M -$6.59M $3.73 63
2024 Q2 9.86M $55.2M -$2.66M $5.60 73
2024 Q1 10.5M $54.8M +$2.57M $5.24 90
2023 Q4 10M $52.4M -$16.5M $5.23 102
2023 Q3 10.3M $163M -$8.34M $15.77 106
2023 Q2 10.8M $209M -$25.5M $19.44 121
2023 Q1 11.8M $334M +$6.36M $28.37 152
2022 Q4 11.6M $338M +$2.93M $29.23 152
2022 Q3 11.5M $303M -$16.4M $26.42 141
2022 Q2 11.6M $516M +$21.3M $44.43 157
2022 Q1 11.2M $555M -$3.38M $49.49 157
2021 Q4 11.3M $573M -$47.7M $50.92 161
2021 Q3 11.8M $660M -$11.3M $55.78 150
2021 Q2 12M $516M -$4.65M $42.80 139
2021 Q1 12.2M $508M -$2.9M $41.74 149
2020 Q4 12.3M $574M -$7.94M $46.57 159
2020 Q3 12.5M $532M -$18.6M $42.48 166
2020 Q2 13M $623M -$13.1M $47.98 160
2020 Q1 13.3M $611M -$10.3M $46.00 165
2019 Q4 13.2M $795M +$5.7M $60.08 176
2019 Q3 13.2M $746M -$18.8M $56.57 181
2019 Q2 13.5M $752M +$12.9M $55.68 177
2019 Q1 13.4M $675M -$20.1M $50.49 176
2018 Q4 13.9M $561M -$101M $40.29 176
2018 Q3 15.4M $1.07B -$2M $69.33 186
2018 Q2 15.4M $1.16B -$26.6M $75.66 181
2018 Q1 15.8M $832M -$8.71M $52.69 170
2017 Q4 16M $852M +$1.04M $53.42 164
2017 Q3 15.7M $938M +$8.01M $59.64 161
2017 Q2 15.3M $1.21B +$315M $78.89 169
2017 Q1 16.4M $1.36B +$96.1M $82.94 145
2016 Q4 16.5M $1.31B -$54.4M $79.34 147
2016 Q3 16.7M $1.17B +$53.7M $70.00 136
2016 Q2 17.2M $667M +$29.4M $38.79 114
2016 Q1 15.4M $625M -$9.3M $40.50 115
2015 Q4 14.9M $1.32B +$76.4M $88.67 133
2015 Q3 14.1M $1.04B +$47.2M $74.03 119
2015 Q2 13.4M $1.08B +$144M $80.86 119
2015 Q1 11.7M $489M +$142M $41.89 68
2014 Q4 9.2M $143M +$21.8M $15.50 28
2014 Q3 2.97M $37.6M +$13.8M $12.65 25
2014 Q2 1.74M $25M -$1.91M $14.33 28
2014 Q1 1.91M $24.4M +$24.4M $12.75 28